Hormones and Cancer

Title Publication Date Language Citations
In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer2010/05/15English216
Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer2014/03/11English183
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions2019/02/02English145
Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers2014/08/15English117
RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review2018/07/09English116
MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer2010/11/19English101
Androgen Receptor Splice Variants in the Era of Enzalutamide and Abiraterone2014/07/22English88
The Weiss Score and Beyond—Histopathology for Adrenocortical Carcinoma2011/10/14English82
Membrane Progesterone Receptors (mPRs) Mediate Progestin Induced Antimorbidity in Breast Cancer Cells and Are Expressed in Human Breast Tumors2012/02/14English77
GPER Mediates Estrogen-Induced Signaling and Proliferation in Human Breast Epithelial Cells and Normal and Malignant Breast2014/04/10English75
A Switch Between Cytoprotective and Cytotoxic Autophagy in the Radiosensitization of Breast Tumor Cells by Chloroquine and Vitamin D2011/09/02English75
Diagnostic Value of Urinary Steroid Profiling in the Evaluation of Adrenal Tumors2015/05/19English73
Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease2015/07/23English73
Estrogen and Progesterone in Normal Mammary Gland Development and in Cancer2010/12/16English72
Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b2014/09/12English70
The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial2014/05/22English67
Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes2010/04/01English63
Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism2011/12/21English63
Microenvironment and Pathogenesis of Epithelial Ovarian Cancer2010/11/30English59
Systematic Review and Meta-analysis of Insulin Therapy and Risk of Cancer2012/04/24English58
Steroid Profiling by Gas Chromatography–Mass Spectrometry and High Performance Liquid Chromatography–Mass Spectrometry for Adrenal Diseases2011/12/01English56
Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events2010/08/01English56
The Link Between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer2014/05/06English55
The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer2016/03/11English55
Prostate Cancer Stem Cells: Do They Have a Basal or Luminal Phenotype?2011/01/04English53
Apigenin Induces Apoptosis and Blocks Growth of Medroxyprogesterone Acetate-Dependent BT-474 Xenograft Tumors2012/05/09English52
TERT Promoter Mutations in Thyroid Cancer2016/02/22English52
Requirement for Stromal Estrogen Receptor Alpha in Cervical Neoplasia2012/10/13English51
Combination Chemotherapy with Cyclophosphamide, Vincristine, and Dacarbazine in Patients with Malignant Pheochromocytoma and Paraganglioma2013/01/30English51
Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues2014/02/26English50